Rogério Martins Amorim

Prof. Dr. Rogério Martins Amorim

Veterinary Clinical, São Paulo State University (UNESP), Botucatu, São Paulo, Brazil, Botucatu, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2014 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
DBDanielle Jaqueta Barberini
Danielle Jaqueta Barberini
NFNatália Pereira Paiva Freitas
Natália Pereira Paiva Freitas
MMMariana Sartori Magnoni
Mariana Sartori Magnoni
LMLeandro Maia
Leandro Maia
ALAmanda Jerônimo Listoni
Amanda Jerônimo Listoni
Rogério Martins AmorimRogério Martins Amorim
Rogério Martins Amorim
Introduction: Studies with mesenchymal stem cells (MSCs) are increasing due to their immunomodulatory, anti-inflammatory and tissue regenerative properties. However, there is still no agreement about the best source of equine MSCs for a bank for allogeneic therapy. The aim of this study was to evaluate the cell culture and immunophenotypic characteristics and differentiation potential of equine MSCs from bone marrow (BM-MSCs), adipose tissue (AT-MSCs) and umbilical cord (UC-MSCs) under identical in vitro conditions, to compare these sources for research or an allogeneic therapy cell bank. Methods: The BM-MSCs, AT-MSCs and UC-MSCs were cultured and evaluated in vitro for their osteogenic, adipogenic and chondrogenic differentiation potential. Additionally, MSCs were assessed for CD105, CD44, CD34, CD90 and MHC-II markers by flow cytometry, and MHC-II was also assessed by immunocytochemistry. To interpret the flow cytometry results, statistical analysis was performed using ANOVA. Results: The harvesting and culturing procedures of BM-MSCs, AT-MSCs and UC-MSCs were feasible, with an average cell growth until the third passage of 25 days for BM-MSCs, 15 days for AT-MSCs and 26 days for UC-MSCs. MSCs from all sources were able to differentiate into osteogenic (after 10 days for BM-MSCs and AT-MSCs and 15 days for UC-MSCs), adipogenic (after 8 days for BM-MSCs and AT-MSCs and 15 days for UC-MSCs) and chondrogenic (after 21 days for BM-MSCs, AT-MSCs and UC-MSCs) lineages. MSCs showed high expression of CD105, CD44 and CD90 and low or negative expression of CD34 and MHC-II. The MHC-II was not detected by immunocytochemistry techniques in any of the MSCs studied. Conclusions: The BM, AT and UC are feasible sources for harvesting equine MSCs, and their immunophenotypic and multipotency characteristics attained minimal criteria for defining MSCs. Due to the low expression of MHC-II by MSCs, all of the sources could be used in clinical trials involving allogeneic therapy in horses. However, the BM-MSCs and AT-MSCs showed fastest ‘‘in vitro’’ differentiation and AT-MSCs showed highest cell growth until third passage. These findings suggest that BM and AT may be preferable for cell banking purposes.

29 May 2021 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
DSDiego Noé Rodríguez Sánchez
Diego Noé Rodríguez Sánchez
GPGiovana Boff Araujo Pinto
Giovana Boff Araujo Pinto
LCLuciana Politti Cartarozzi
Luciana Politti Cartarozzi
Alexandre OliveiraAlexandre Oliveira
Alexandre Oliveira
ABAna Livia Carvalho Bovolato
Ana Livia Carvalho Bovolato
Rogério Martins AmorimRogério Martins Amorim
Rogério Martins Amorim
Background: Nerve injuries are debilitating, leading to long-term motor deficits. Remyelination and axonal growth are supported and enhanced by growth factor and cytokines. Combination of nerve guidance conduits (NGCs) with adipose-tissue-derived multipotent mesenchymal stromal cells (AdMSCs) has been performing promising strategy for nerve regeneration. Methods: 3D-printed polycaprolactone (PCL)-NGCs were fabricated. Wistar rats subjected to critical sciatic nerve damage (12-mm gap) were divided into sham, autograft, PCL (empty NGC), and PCL + MSCs (NGC multi-functionalized with 106 canine AdMSCs embedded in heterologous fibrin biopolymer) groups. In vitro, the cells were characterized and directly stimulated with interferon-gamma to evaluate their neuroregeneration potential. In vivo, the sciatic and tibial functional indices were evaluated for 12 weeks. Gait analysis and nerve conduction velocity were analyzed after 8 and 12 weeks. Morphometric analysis was performed after 8 and 12 weeks following lesion development. Real-time PCR was performed to evaluate the neurotrophic factors BDNF, GDNF, and HGF, and the cytokine and IL-10. Immunohistochemical analysis for the p75NTR neurotrophic receptor, S100, and neurofilament was performed with the sciatic nerve. Results: The inflammatory environment in vitro have increased the expression of neurotrophins BDNF, GDNF, HGF, and IL-10 in canine AdMSCs. Nerve guidance conduits multi-functionalized with canine AdMSCs embedded in HFB improved functional motor and electrophysiological recovery compared with PCL group after 12 weeks. However, the results were not significantly different than those obtained using autografts. These findings were associated with a shift in the regeneration process towards the formation of myelinated fibers. Increased immunostaining of BDNF, GDNF, and growth factor receptor p75NTR was associated with the upregulation of BDNF, GDNF, and HGF in the spinal cord of the PCL + MSCs group. A trend demonstrating higher reactivity of Schwann cells and axonal branching in the sciatic nerve was observed, and canine AdMSCs were engrafted at 30 days following repair. Conclusions: 3D-printed NGCs multi-functionalized with canine AdMSCs embedded in heterologous fibrin biopolymer as cell scaffold exerted neuroregenerative effects. Our multimodal approach supports the trophic microenvironment, resulting in a pro-regenerative state after critical sciatic nerve injury in rats.

10 April 2018 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
DBDanielle Jaqueta Barberini
Danielle Jaqueta Barberini
MAMonica Aleman
Monica Aleman
FAFabio Aristizabal
Fabio Aristizabal
MSMathieu Spriet
Mathieu Spriet
KCKaitlin Clark
Kaitlin Clark
DBDori L. Borjesson
Dori L. Borjesson
It is currently unknown if the intrathecal administration of a high dose of allogeneic mesenchymal stem cells (MSCs) is safe, how MSCs migrate throughout the vertebral canal after intrathecal administration, and whether MSCs are able to home to a site of injury. The aims of the study were: 1) to evaluate the safety of intrathecal injection of 100 million allogeneic adipose-derived MSCs (ASCs); 2) to assess the distribution of ASCs after atlanto-occipital (AO) and lumbosacral (LS) injection in healthy horses; and 3) to determine if ASCs homed to the site of injury in neurologically diseased horses. Six healthy horses received 100 × 106 allogeneic ASCs via AO (n = 3) or LS injection (n = 3). For two of these horses, ASCs were radiolabeled with technetium and injected AO (n = 1) or LS (n = 1). Neurological examinations were performed daily, and blood and cerebrospinal fluid (CSF) were evaluated prior to and at 30 days after injection. Scintigraphic images were obtained immediately postinjection and at 30 mins, 1 h, 5 h, and 24 h after injection. Three horses with cervical vertebral compressive myelopathy (CVCM) received 100 × 106 allogeneic ASCs labeled with green fluorescent protein (GFP) via AO injection and were euthanized 1–2 weeks after injection for a full nervous system necropsy. CSF parameters were compared using a paired student’s t test. There were no significant alterations in blood, CSF, or neurological examinations at any point after either AO or LS ASC injections into healthy horses. The radioactive signal could be identified all the way to the lumbar area after AO ASC injection. After LS injection, the signal extended caudally but only a minimal radioactive signal extended further cranially. GFP-labeled ASCs were not present at the site of disease at either 1 or 2 weeks following intrathecal administration. The intrathecal injection of allogeneic ASCs was safe and easy to perform in horses. The AO administration of ASCs resulted in better distribution within the entire subarachnoid space in healthy horses. ASCs could not be found after 7 or 15 days of injection at the site of injury in horses with CVCM.

1 April 2011 in Veterinary Parasitology
Verified
Journal Article
Closed access
Helio LangoniHelio Langoni
Helio Langoni
HGHaroldo Greca
Haroldo Greca
FGFelipe Guimarães
Felipe Guimarães
LULeila S. Ullmann
Leila S. Ullmann
FGFernanda C. Gaio
Fernanda C. Gaio
RSRodrigo Costa da Silva
Rodrigo Costa da Silva

28 October 2018 in Cell Transplantation
Verified
Journal Article
Open access
PDF file
DSDiego Noé Rodríguez Sánchez
Diego Noé Rodríguez Sánchez
LRLuiz Antonio de Lima Resende
Luiz Antonio de Lima Resende
GPGiovana Boff Araujo Pinto
Giovana Boff Araujo Pinto
ABAna Lívia de Carvalho Bovolato
Ana Lívia de Carvalho Bovolato
FPFabio Sossai Possebon
Fabio Sossai Possebon
Rogério Martins AmorimRogério Martins Amorim
Rogério Martins Amorim
Crush injuries in peripheral nerves are frequent and induce long-term disability with motor and sensory deficits. Due to axonal and myelin sheath disruptions, strategies for optimized axonal regeneration are needed. Multipotent mesenchymal stromal cells (MSC) are promising because of their anti-inflammatory properties and secretion of neurotrophins. The present study investigated the effect of canine adipose tissue MSC (Ad-MSC) transplantation in an experimental sciatic nerve crush injury. Wistar rats were divided into three groups: sham (n = 8); Crush+PBS (n = 8); Crush+MSC (n = 8). Measurements of sciatic nerve functional index (SFI), muscle mass, and electromyography (EMG) were performed. Canine Ad-MSC showed mesodermal characteristics (CD34-, CD45-, CD44+, CD90+ and CD105+) and multipotentiality due to chondrogenic, adipogenic, and osteogenic differentiation. SFI during weeks 3 and 4 was significantly higher in the Crush+MSC group (p < 0.001). During week 4, the EMG latency in the Crush+MSC groups had better near normality (p < 0.05). The EMG amplitude showed results close to normality during week 4 in the Crush+MSC group (p < 0.04). There were no statistical differences in muscle weight between the groups (p > 0.05), but there was a tendency toward weight gain in the Crush+MSC groups. Better motor functional recovery after crush and perineural canine Ad-MSC transplantation was observed during week 2. This was maintained till week 4. In conclusion, the canine Ad-MSC transplantation showed early pro-regenerative effects between 2–4 weeks in the rat model of sciatic nerve crush injury.

27 March 2013 in Microscopy Research and Technique
Verified
Journal Article
Closed access
PDF file
LMLeandro Maia
Leandro Maia
FLFernanda da Cruz Landim-Alvarenga
Fernanda da Cruz Landim-Alvarenga
LMLígia Souza Lima Silveira da Mota
Lígia Souza Lima Silveira da Mota
MGMarjorie de Assis Golim
Marjorie de Assis Golim
RLRenee Laufer-Amorim
Renee Laufer-Amorim
Rogério Martins AmorimRogério Martins Amorim
Rogério Martins Amorim